« MassBio Healthcare Reform - Point/Counterpoint | Main | Sanofi-Aventis Covers It's Bases »

04/02/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01347f996dcf970c

Listed below are links to weblogs that reference Sweet Gene Ruling - Stinks? Or Breath of Fresh Air?:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce Lehr

Nature Biotech also reports that a UK court voided a gene patent held by HGS for the neutrokine-a gene sequence as they did not have data to support its biological effects. HGS has licenses with both GSK (lupus) and Eli Lilly - reportedly who has spent $50 M in developing antibodies to neutrokine-a and with plans to spend $250 M in clinical trials.

http://www.nature.com/nbt/journal/v28/n4/full/nbt0410-300b.html

Bruce Lehr

The Patent Docs blog has additional good coverage on this story - in particular providing links to "60 Minutes" and PBS Newshour coverage of the story. http://bit.ly/dthRqd

Pharma Conduct Guy

Great post on a very timely topic.

Bruce Lehr

The Patent Docs blog has some good coverage regarding what other medical organizations are saying about the Sweet decision on gene patents.
http://bit.ly/bsrFSN

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada